Mostra i principali dati dell'item

dc.contributor.authorGuida, Maurizio
dc.contributor.authorMarra, Marialuisa
dc.contributor.authorPalatucci, Valeria
dc.contributor.authorPascale, Renato
dc.contributor.authorVisconti, Federica
dc.contributor.authorZullo, Fulvio
dc.date.accessioned2013-04-03T12:47:29Z
dc.date.available2013-04-03T12:47:29Z
dc.date.issued2011
dc.identifier.citationGuida M, Marra ML, Palatucci V, Pascale R, Visconti F, Zullo F. Emergency contraception: an updated review. Translational Medicine @ UniSa 2011;1(1):271-294en_US
dc.identifier.issn2239-9747en_US
dc.identifier.urihttp://hdl.handle.net/10556/518
dc.description.abstractEmergency contraception is a common practice now. Many categories of drugs are marketed with modifications in dosage, in combination and even in the timing of administration. Recent re-analysis suggests that there is still no uniformity of opinion on the actual mechanism of action and this has often fueled the ethical controversy. This review analyzes the most common emergency contraception drugs: levonorgestrel, mifepristone and ulipristal acetate about their action underlining that the hormonal products, when used in emergency contraception, play different roles depending on the phase of the menstrual cycle during which they are administered.This review aims to examine rigorously the most accredited literature to verify if a evidence-based uniformity of opinions has been achieved about the biological effects of hormones administered after the sexual intercourse.en_US
dc.format.extentP. 271-294en_US
dc.language.isoenen_US
dc.sourceUniSa. Sistema Bibliotecario di Ateneoen_US
dc.subjectEmergency contraceptionen_US
dc.subjectLevonorgestrelen_US
dc.subjectMifepristoneen_US
dc.subjectUlipristal acetateen_US
dc.titleEmergency contraception: an updated reviewen_US
dc.typeArticleen_US
 Find Full text

Files in questo item

Thumbnail

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item